Bank of America
BCAB icon

Bank of America’s BioAtla BCAB Stock Holding History

Bank of America’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$245 – 5810
2025
Q4 		$245 Buy
9
+1
+13% +$39 ﹤0.01% 6667
2025
Q3 		$287 Sell
8
-2
-20% -$46 ﹤0.01% 7677
2025
Q2 		$189 Buy
10
+2
+25% +$41 ﹤0.01% 7854
2025
Q1 		$145 Sell
8
-309
-97% -$6.61K ﹤0.01% 7759
2024
Q4 		$9.37K Sell
317
-484
-60% -$40.6K ﹤0.01% 6996
2024
Q3 		$70.5K Buy
801
+778
+3,383% +$65.2K ﹤0.01% 6456
2024
Q2 		$1.58K Sell
23
-280
-92% -$33.3K ﹤0.01% 7172
2024
Q1 		$52K Sell
303
-571
-65% -$70.9K ﹤0.01% 6503
2023
Q4 		$107K Buy
874
+296
+51% +$25.7K ﹤0.01% 6349
2023
Q3 		$49.2K Buy
578
+162
+39% +$20.6K ﹤0.01% 6511
2023
Q2 		$62.4K Buy
416
+16
+4% +$2.75K ﹤0.01% 6374
2023
Q1 		$53.6K Sell
400
-561
-58% -$101K ﹤0.01% 6485
2022
Q4 		$396K Sell
961
-78
-8% -$32.4K ﹤0.01% 5540
2022
Q3 		$400K Sell
1,039
-3
-0.3% -$982 ﹤0.01% 5559
2022
Q2 		$148K Sell
1,042
-1,155
-53% -$184K ﹤0.01% 6285
2022
Q1 		$549K Buy
2,197
+1,322
+151% +$553K ﹤0.01% 5761
2021
Q4 		$859K Buy
875
+690
+373% +$883K ﹤0.01% 5420
2021
Q3 		$273K Sell
185
-32
-15% -$62.3K ﹤0.01% 6079
2021
Q2 		$461K Buy
217
+35
+19% +$79.1K ﹤0.01% 5498
2021
Q1 		$462K Buy
182
+179
+5,967% +$459K ﹤0.01% 5433
2020
Q4 		$6K Buy
+3
New +$5.01K ﹤0.01% 6799

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's BCAB Position: Q1 2026 in Review

Bank of America sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 9 shares — an estimated $245 sold.

Bank of America first reported a position in BCAB in Q4 2020 and held it in 21 quarters. The position peaked at $859K in Q4 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Bank of America reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 9 BioAtla shares in Q1 2026, an estimated $245.
  • Bank of America first reported a position in BioAtla in Q4 2020 and held it in 21 quarters.
  • Bank of America's BioAtla position peaked at $859K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.